FDA doubles dosage of Covid-19 monoclonal antibody, raising concerns about access and supply - 1brea

  • 2 years ago
The US Food and Drug Administration on Thursday revised the emergency use authorization for Evusheld, a monoclonal antibody against Covid-19 for immunocompromised people and those who cannot be vaccinated for medical reasons, to double the initial dose ...

VIEW MORE : https://bit.ly/1breakingnews

Recommended